High levels of soluble syndecan-1 in myeloma-derived bone marrow: Modulation of hepatocyte growth factor activity

Blood

Volumn 96, Issue 9, 2000, Pages 3139-3146

  Seidel, C ^a   Borset, M ^a   Hjertner, O ^a   Cao, D ^a   Abildgaard, N ^a   Hjorth Hansen, H ^a   Sanderson, R D ^a   Waage, A ^a   Sundan, A ^a  

^a Institute of Cancer Research and Molecular Biology   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GLYCOSAMINOGLYCAN; GROWTH FACTOR; SCATTER FACTOR; SYNDECAN;

APOPTOSIS; ARTICLE; BINDING SITE; BONE MARROW CELL; CELL ADHESION; CELL INTERACTION; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MESENCHYME CELL; MYELOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0034329194     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.9.3139     Document Type: Article

References (52)

1. Growth factors in the extracellular matrix
2. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1
3. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen
4. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: Control of tumor cell survival, growth, and bone cell differentiation
5. Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma
6. Fibronectin and its receptors
7. Expression of syndecan-1 inhibits cell invasion into type I collagen
8. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican
9. Rapid induction of hepatocyte growth factor by heparin
10. Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals
11. Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepato-cellular carcinoma
12. Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin
13. Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: A multifunctional regulator of cell behavior within the tumor microenvironment
14. Serum syndecan-1: A new independent prognostic marker in multiple myeloma
15. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species
16. Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines
17. Hepatocyte growth factor and its receptor c-met in multiple myeloma
18. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma: The Nordic Myeloma Study Group
19. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro
20. Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6)
21. Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: A possible role for HGF in myeloma-associated osteolytic bone disease
22. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor
23. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
24. Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 and JJN-2) which proliferate in response to B cell stimulatory factor 2
25. TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line
26. Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain
27. Combined alcian blue and silver staining of subnanogram quantities of proteoglycans and glycosaminoglycans in sodium dodecyl sulfate-polyacrylamide gels
28. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2
29. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
30. Transforming growth factor-beta 1 is a heparin-binding protein: Identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1
31. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity
32. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor
33. Natural hepatocyte growth factor (HGF) from human serum and a bound form of recombinant HGF with heparan sulfate are indistinguishable in their physicochemical properties
34. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes
35. Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes
36. Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats
37. Heparin-hepatocyte growth factor complex with low plasma clearance and retained hepatocyte proliferating activity
38. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met
39. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2
40. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms: Heparan sulfate glycosaminoglycan requirement for Met binding and signaling
41. Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains
42. Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity
43. Heparin as an inducer of hepatocyte growth factor
44. Identification and partial characterization of receptor binding sites for HGF on rat hepatocytes
45. NH2-terminal amino acid sequence of rabbit hepatopoietin A, a heparin-binding polypeptide growth factor for hepatocytes
46. Smooth muscle releases an epithelial cell scatter factor which binds to heparin
47. Interleukin-11: A new cytokine critical for osteoclast development
48. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo
49. Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis
50. Regulation of distinct steps of angiogenesis by different angiogenic molecules
51. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
52. Scatter factor affects major changes in the cytoskeletal organization of epithelial cells